For: | Herreros-Villanueva M, Hijona E, Cosme A, Bujanda L. Mouse models of pancreatic cancer. World J Gastroenterol 2012; 18(12): 1286-1294 [PMID: 22493542 DOI: 10.3748/wjg.v18.i12.1286] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i12/1286.htm |
Number | Citing Articles |
1 |
Luigi Leanza, Matteo Romio, Katrin Anne Becker, Michele Azzolini, Livio Trentin, Antonella Managò, Elisa Venturini, Angela Zaccagnino, Andrea Mattarei, Luca Carraretto, Andrea Urbani, Stephanie Kadow, Lucia Biasutto, Veronica Martini, Filippo Severin, Roberta Peruzzo, Valentina Trimarco, Jan-Hendrik Egberts, Charlotte Hauser, Andrea Visentin, Gianpietro Semenzato, Holger Kalthoff, Mario Zoratti, Erich Gulbins, Cristina Paradisi, Ildiko Szabo. Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo. Cancer Cell 2017; 31(4): 516 doi: 10.1016/j.ccell.2017.03.003
|
2 |
Natacha Jugniot, Rakesh Bam, Emmanuelle J. Meuillet, Evan C. Unger, Ramasamy Paulmurugan. Current status of targeted microbubbles in diagnostic molecular imaging of pancreatic cancer. Bioengineering & Translational Medicine 2021; 6(1) doi: 10.1002/btm2.10183
|
3 |
Iris H. Wei, Chandan Kumar-Sinha. Molecular Genetics of Pancreatic Cancer. 2013; : 209 doi: 10.1007/978-1-4614-6549-2_10
|
4 |
Abakundana Nsenga Ariston Gabriel, Qinlian Jiao, Umwali Yvette, Xuemei Yang, Samed A. Al-Ameri, Lutao Du, Yun-shan Wang, Chuanxin Wang. Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevance. Pancreatology 2020; 20(1): 79 doi: 10.1016/j.pan.2019.11.006
|
5 |
Manoj K. Bhasin, Kenneth Ndebele, Octavian Bucur, Eric U. Yee, Hasan H. Otu, Jessica Plati, Andrea Bullock, Xuesong Gu, Eduardo Castan, Peng Zhang, Robert Najarian, Maria S. Muraru, Rebecca Miksad, Roya Khosravi-Far, Towia A. Libermann. Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier. Oncotarget 2016; 7(17): 23263 doi: 10.18632/oncotarget.8139
|
6 |
Magdalena Swierczewska, Serguei Kozlov, Pavan P. Adiseshaiah. Oncogenomics. 2019; : 313 doi: 10.1016/B978-0-12-811785-9.00022-3
|
7 |
Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune, Mitsunobu R. Kano. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment. Cancers 2023; 15(3): 724 doi: 10.3390/cancers15030724
|
8 |
Su Hu, Liang Pan, Junjie Shangguan, Matteo Figini, Aydin Eresen, Chong Sun, Bin Wang, Quanhong Ma, Chunhong Hu, Vahid Yaghmai, Yuri Velichko, Jia Yang, Zhuoli Zhang. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model. Journal of Immunological Methods 2019; 465: 1 doi: 10.1016/j.jim.2018.11.009
|
9 |
Sunita Shankar, Jean Ching-Yi Tien, Ronald F. Siebenaler, Seema Chugh, Vijaya L. Dommeti, Sylvia Zelenka-Wang, Xiao-Ming Wang, Ingrid J. Apel, Jessica Waninger, Sanjana Eyunni, Alice Xu, Malay Mody, Andrew Goodrum, Yuping Zhang, John J. Tesmer, Rahul Mannan, Xuhong Cao, Pankaj Vats, Sethuramasundaram Pitchiaya, Stephanie J. Ellison, Jiaqi Shi, Chandan Kumar-Sinha, Howard C. Crawford, Arul M. Chinnaiyan. An essential role for Argonaute 2 in EGFR-KRAS signaling in pancreatic cancer development. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-16309-2
|
10 |
Ying Ji, Xiangsheng Liu, Juan Li, Xiaodong Xie, Max Huang, Jinhong Jiang, Yu-Pei Liao, Timothy Donahue, Huan Meng. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-17996-7
|
11 |
Ilaria Pergolini, Vicente Morales-Oyarvide, Mari Mino-Kenudson, Kim C. Honselmann, Matthew W. Rosenbaum, Sabikun Nahar, Marina Kem, Cristina R. Ferrone, Keith D. Lillemoe, Nabeel Bardeesy, David P. Ryan, Sarah P. Thayer, Andrew L. Warshaw, Carlos Fernández-del Castillo, Andrew S. Liss, Ilse Rooman. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival. PLOS ONE 2017; 12(8): e0182855 doi: 10.1371/journal.pone.0182855
|
12 |
Erica S. Tsang, James T. Topham, Joanna M. Karasinska, Michael K.C. Lee, Laura M. Williamson, Shehara Mendis, Robert E. Denroche, Gun Ho Jang, Steve E. Kalloger, Richard A. Moore, Andrew J. Mungall, Oliver F. Bathe, Patricia A. Tang, Faiyaz Notta, Julie M. Wilson, Janessa Laskin, Grainne M. O'Kane, Jennifer J. Knox, Rachel A. Goodwin, Jonathan M. Loree, Steven J.M. Jones, Marco A. Marra, Steven Gallinger, David F. Schaeffer, Daniel J. Renouf. Delving into Early-onset Pancreatic Ductal Adenocarcinoma: How Does Age Fit In?. Clinical Cancer Research 2021; 27(1): 246 doi: 10.1158/1078-0432.CCR-20-1042
|
13 |
Allison S. Cohen, Jun Li, Matthew R. Hight, Eliot McKinley, Allie Fu, Adria Payne, Yang Liu, Dawei Zhang, Qing Xie, Mingfeng Bai, Gregory D. Ayers, Mohammed Noor Tantawy, Jarrod A. Smith, Frank Revetta, M. Kay Washington, Chanjuan Shi, Nipun Merchant, H. Charles Manning. TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions. Clinical Cancer Research 2020; 26(22): 5914 doi: 10.1158/1078-0432.CCR-20-1214
|
14 |
Wenxin Zheng, Kinga B. Skowron, Jukes P. Namm, Byron Burnette, Christian Fernandez, Ainhoa Arina, Hua Liang, Michael T. Spiotto, Mitchell C. Posner, Yang-Xin Fu, Ralph R. Weichselbaum. Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance. Oncotarget 2016; 7(28): 43039 doi: 10.18632/oncotarget.9915
|
15 |
Christian Eberhardt, Moritz C. Wurnig, Andrea Wirsching, Cristina Rossi, Markus Rottmar, Pinar S. Özbay, Lukas Filli, Mickael Lesurtel, Andreas Boss. Intravoxel incoherent motion analysis of abdominal organs: computation of reference parameters in a large cohort of C57Bl/6 mice and correlation to microvessel density. Magnetic Resonance Materials in Physics, Biology and Medicine 2016; 29(5): 751 doi: 10.1007/s10334-016-0540-9
|
16 |
Marta Herreros-Villanueva, Meritxel Gironella, Antoni Castells, Luis Bujanda. Molecular markers in pancreatic cancer diagnosis. Clinica Chimica Acta 2013; 418: 22 doi: 10.1016/j.cca.2012.12.025
|
17 |
Tomohiro Maekawa, Risako Fukaya, Shinji Takamatsu, Saki Itoyama, Tomoya Fukuoka, Makoto Yamada, Tomoki Hata, Satoshi Nagaoka, Koichi Kawamoto, Hidetoshi Eguchi, Kohei Murata, Takashi Kumada, Toshifumi Ito, Masahiro Tanemura, Kahoko Fujimoto, Yasuhiko Tomita, Toru Tobe, Yoshihiro Kamada, Eiji Miyoshi. Possible involvement of Enterococcus infection in the pathogenesis of chronic pancreatitis and cancer. Biochemical and Biophysical Research Communications 2018; 506(4): 962 doi: 10.1016/j.bbrc.2018.10.169
|
18 |
Matthew A. Huber, Sandeep Nadella, Hong Cao, Bhaskar Kallakury, Robin D. Tucker, Martha D. Gay, Narayan Shivapurkar, Elijah F. Edmondson, Yuanzhen Yue, Wenyu Dou, Hong-Bin Fang, Jill P. Smith. Does Chronic Use of High Dose Proton Pump Inhibitors Increase Risk for Pancreatic Cancer?. Pancreas 2022; 51(9): 1118 doi: 10.1097/MPA.0000000000002145
|
19 |
A J Rice, E Cortes, D Lachowski, B C H Cheung, S A Karim, J P Morton, A del Río Hernández. Matrix stiffness induces epithelial–mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogenesis 2017; 6(7): e352 doi: 10.1038/oncsis.2017.54
|
20 |
Assaf Zinger, Lilach Koren, Omer Adir, Maria Poley, Mohammed Alyan, Zvi Yaari, Nadav Noor, Nitzan Krinsky, Assaf Simon, Hadas Gibori, Majd Krayem, Yelena Mumblat, Shira Kasten, Sivan Ofir, Eran Fridman, Neta Milman, Michael M. Lübtow, Lior Liba, Jeny Shklover, Janna Shainsky-Roitman, Yoav Binenbaum, Dov Hershkovitz, Ziv Gil, Tal Dvir, Robert Luxenhofer, Ronit Satchi-Fainaro, Avi Schroeder. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors. ACS Nano 2019; 13(10): 11008 doi: 10.1021/acsnano.9b02395
|
21 |
Erik S Knudsen, Uthra Balaji, Brian Mannakee, Paris Vail, Cody Eslinger, Christopher Moxom, John Mansour, Agnieszka K Witkiewicz. Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Gut 2018; 67(3): 508 doi: 10.1136/gutjnl-2016-313133
|
22 |
Mónica Gabriela Sánchez-Salazar, Mario Moisés Álvarez, G. Trujillo-de Santiago. Advances in 3D bioprinting for the biofabrication of tumor models. Bioprinting 2021; 21: e00120 doi: 10.1016/j.bprint.2020.e00120
|
23 |
Claudia Minici, Sabrina Testoni, Emanuel Della-Torre. B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.867902
|
24 |
Benjamin L. Johnson, Marcela d’Alincourt Salazar, Sarah Mackenzie-Dyck, Massimo D’Apuzzo, Hung Ping Shih, Edwin R. Manuel, Don J. Diamond, Francisco X. Real. Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice. PLOS ONE 2019; 14(9): e0221810 doi: 10.1371/journal.pone.0221810
|
25 |
Claire Bouvard, Colleen Barefield, Shoutian Zhu. Cancer Stem Cells as a Target Population for Drug Discovery. Future Medicinal Chemistry 2014; 6(14): 1567 doi: 10.4155/fmc.14.106
|
26 |
Nicolas Jonckheere, Romain Vasseur, Isabelle Van Seuningen. The cornerstone K-RAS mutation in pancreatic adenocarcinoma: From cell signaling network, target genes, biological processes to therapeutic targeting. Critical Reviews in Oncology/Hematology 2017; 111: 7 doi: 10.1016/j.critrevonc.2017.01.002
|
27 |
Toya M. Albury, Veethika Pandey, Sarah B. Gitto, Lisette Dominguez, Lina P. Spinel, Jacqueline Talarchek, Andres J. Klein-Szanto, Joseph R. Testa, Deborah A. Altomare. Constitutively Active Akt1 Cooperates with KRasG12D to Accelerate In Vivo Pancreatic Tumor Onset and Progression. Neoplasia 2015; 17(2): 175 doi: 10.1016/j.neo.2014.12.006
|
28 |
Nelson S. Yee, Abid A. Kazi, Rosemary K. Yee. Translating Discovery in Zebrafish Pancreatic Development to Human Pancreatic Cancer: Biomarkers, Targets, Pathogenesis, and Therapeutics. Zebrafish 2013; 10(2): 132 doi: 10.1089/zeb.2012.0817
|
29 |
Yoo Jin Chang, Jihyeon Bae, Yang Zhao, Geonseong Lee, Jeongpil Han, Yoon Hoo Lee, Ok Jae Koo, Sunmin Seo, Yang-Kyu Choi, Su Cheong Yeom. In vivo multiplex gene targeting with Streptococcus pyogens and Campylobacter jejuni Cas9 for pancreatic cancer modeling in wild-type animal. Journal of Veterinary Science 2020; 21(2) doi: 10.4142/jvs.2020.21.e26
|
30 |
Reinhild Holmer, Freya A Goumas, Georg H Waetzig, Stefan Rose-John, Holger Kalthoff. Interleukin-6: a villain in the drama of pancreatic cancer development and progression. Hepatobiliary & Pancreatic Diseases International 2014; 13(4): 371 doi: 10.1016/S1499-3872(14)60259-9
|
31 |
Nagaraj S. Nagathihalli, Jason A. Castellanos, Chanjuan Shi, Yugandhar Beesetty, Michelle L. Reyzer, Richard Caprioli, Xi Chen, Alex J. Walsh, Melissa C. Skala, Harold L. Moses, Nipun B. Merchant. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer. Gastroenterology 2015; 149(7): 1932 doi: 10.1053/j.gastro.2015.07.058
|
32 |
Stéphanie I. De Vleeschauwer, Marieke van de Ven, Anaïs Oudin, Karlijn Debusschere, Kate Connor, Annette T. Byrne, Doreen Ram, Anne Marie Rhebergen, Yannick D. Raeves, Maik Dahlhoff, Virginie Dangles-Marie, Els R. Hermans. OBSERVE: guidelines for the refinement of rodent cancer models. Nature Protocols 2024; 19(9): 2571 doi: 10.1038/s41596-024-00998-w
|
33 |
Ramesh Pothuraju, Satyanarayana Rachagani, Wade M. Junker, Sanjib Chaudhary, Viswanathan Saraswathi, Sukhwinder Kaur, Surinder K. Batra. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0963-4
|
34 |
Xinxia Zhu, Kevin G. Burfeind, Katherine A. Michaelis, Theodore P. Braun, Brennan Olson, Katherine R. Pelz, Terry K. Morgan, Daniel L. Marks. MyD88 signalling is critical in the development of pancreatic cancer cachexia. Journal of Cachexia, Sarcopenia and Muscle 2019; 10(2): 378 doi: 10.1002/jcsm.12377
|
35 |
Xiaolin Li, Tosca Holtrop, Fleur A.C. Jansen, Brennan Olson, Pete Levasseur, Xinxia Zhu, Mieke Poland, Winni Schalwijk, Renger F. Witkamp, Daniel L. Marks, Klaske van Norren. Lipopolysaccharide‐induced hypothalamic inflammation in cancer cachexia‐anorexia is amplified by tumour‐derived prostaglandin E2. Journal of Cachexia, Sarcopenia and Muscle 2022; 13(6): 3014 doi: 10.1002/jcsm.13093
|
36 |
Jun-Chao Guo, Jian Li, Ying-Chi Yang, Li Zhou, Tai-Ping Zhang, Yu-Pei Zhao, William B. Coleman. Oligonucleotide Microarray Identifies Genes Differentially Expressed during Tumorigenesis of DMBA-Induced Pancreatic Cancer in Rats. PLoS ONE 2013; 8(12): e82910 doi: 10.1371/journal.pone.0082910
|
37 |
Milena Armacki, Sandra Polaschek, Mareike Waldenmaier, Mareen Morawe, Claudia Ruhland, Rebecca Schmid, André Lechel, Umesh Tharehalli, Christoph Steup, Yasin Bektas, Hongxia Li, Johann M. Kraus, Hans A. Kestler, Stephan Kruger, Steffen Ormanns, Paul Walther, Tim Eiseler, Thomas Seufferlein. Protein Kinase D1, Reduced in Human Pancreatic Tumors, Increases Secretion of Small Extracellular Vesicles From Cancer Cells That Promote Metastasis to Lung in Mice. Gastroenterology 2020; 159(3): 1019 doi: 10.1053/j.gastro.2020.05.052
|
38 |
Kinam Park, You Han Bae, Randall J. Mrsny. Cancer Targeted Drug Delivery. 2013; : 689 doi: 10.1007/978-1-4614-7876-8_26
|
39 |
Barbara Grünwald, Jennifer Vandooren, Michael Gerg, Kaarin Ahomaa, Annique Hunger, Sonja Berchtold, Sophia Akbareian, Susanne Schaten, Percy Knolle, Dylan R. Edwards, Ghislain Opdenakker, Achim Krüger. Systemic Ablation of MMP-9 Triggers Invasive Growth and Metastasis of Pancreatic Cancer via Deregulation of IL6 Expression in the Bone Marrow. Molecular Cancer Research 2016; 14(11): 1147 doi: 10.1158/1541-7786.MCR-16-0180
|
40 |
Madanraj Appiya Santharam, Vignesh Dhandapani. Exploring Pancreatic Metabolism and Malignancy. 2019; : 133 doi: 10.1007/978-981-32-9393-9_8
|
41 |
Cheng-Fang Wang, Xian-Jie Shi. Generation and application of patient-derived xenograft models in pancreatic cancer research. Chinese Medical Journal 2019; 132(22): 2729 doi: 10.1097/CM9.0000000000000524
|
42 |
Meng-Dan Xu, Shu-Ling Liu, Yi-Zhong Feng, Qiang Liu, Meng Shen, Qiaoming Zhi, Zeyi Liu, Dong-Mei Gu, Jie Yu, Liu-Mei Shou, Fei-Ran Gong, Qi Zhu, Weiming Duan, Kai Chen, Junning Zhang, Meng-Yao Wu, Min Tao, Wei Li. Genomic characteristics of pancreatic squamous cell carcinoma, an investigation by using high throughput sequencing after in-solution hybrid capture. Oncotarget 2017; 8(9): 14620 doi: 10.18632/oncotarget.14678
|
43 |
Yoshihiro Kaneta, Takeshi Sato, Yohko Hikiba, Makoto Sugimori, Soichiro Sue, Hiroaki Kaneko, Kuniyasu Irie, Tomohiko Sasaki, Masaaki Kondo, Makoto Chuma, Wataru Shibata, Shin Maeda. Loss of Pancreatic E-Cadherin Causes Pancreatitis-Like Changes and Contributes to Carcinogenesis. Cellular and Molecular Gastroenterology and Hepatology 2020; 9(1): 105 doi: 10.1016/j.jcmgh.2019.09.001
|
44 |
Namrata Khurana, Paarth B. Dodhiawala, Ashenafi Bulle, Kian-Huat Lim. Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer. Cancers 2020; 12(9): 2675 doi: 10.3390/cancers12092675
|
45 |
Lingyi Sun, Yongkang Gai, Zhonghan Li, Huiqiang Li, Jianchun Li, John Muschler, Rui Kang, Daolin Tang, Dexing Zeng. Heterodimeric RGD-NGR PET Tracer for the Early Detection of Pancreatic Cancer. Molecular Imaging and Biology 2022; 24(4): 580 doi: 10.1007/s11307-022-01704-6
|
46 |
Jiahui Yuan, Zeyao Zhu, Pingping Zhang, Milad Ashrafizadeh, A.M. Abd El-Aty, Ahmet Hacımüftüoğlu, Christina Susanne Linnebacher, Michael Linnebacher, Gautam Sethi, Peng Gong, Xianbin Zhang. SKP2 promotes the metastasis of pancreatic ductal adenocarcinoma by suppressing TRIM21-mediated PSPC1 degradation. Cancer Letters 2024; 587: 216733 doi: 10.1016/j.canlet.2024.216733
|
47 |
Suprit Gupta, Avi Prajapati, Mansi Gulati, Shailendra K. Gautam, Sushil Kumar, Vipin Dalal, Geoffrey A. Talmon, Satyanarayana Rachagani, Maneesh Jain. Irreversible and sustained upregulation of endothelin axis during oncogene-associated pancreatic inflammation and cancer. Neoplasia 2020; 22(2): 98 doi: 10.1016/j.neo.2019.11.001
|
48 |
Ying-Cheng Chen, Ying-Wei Lan, Shiaw-Min Huang, Chih-Ching Yen, Wei Chen, Wan-Ju Wu, Theresa Staniczek, Kowit-Yu Chong, Chuan-Mu Chen. Human amniotic fluid mesenchymal stem cells attenuate pancreatic cancer cell proliferation and tumor growth in an orthotopic xenograft mouse model. Stem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02910-3
|
49 |
Anna Gams, Alejandro Nevarez, Stephanie Perkail, Aileen Venegas, Sharon A. George, Tatiana Efimova, Igor R. Efimov. Evidence of sex differences in cancer‐related cardiac complications in mouse models of pancreatic and liver cancer. Physiological Reports 2023; 11(8) doi: 10.14814/phy2.15672
|
50 |
Shannon R. Nelson, Naomi Walsh. Genetic Alterations Featuring Biological Models to Tailor Clinical Management of Pancreatic Cancer Patients. Cancers 2020; 12(5): 1233 doi: 10.3390/cancers12051233
|
51 |
Sujit Suklabaidya, Pujarini Dash, Biswajit Das, Voddu Suresh, Prakash K Sasmal, Shantibhusan Senapati. Experimental models of pancreatic cancer desmoplasia. Laboratory Investigation 2018; 98(1): 27 doi: 10.1038/labinvest.2017.127
|
52 |
Bernat Navarro-Serer, Laura D. Wood. Organoids. Pancreas 2022; 51(6): 608 doi: 10.1097/MPA.0000000000002084
|
53 |
Marco Schiavone, Elena Rampazzo, Alessandro Casari, Giusy Battilana, Luca Persano, Enrico Moro, Shu Liu, Steven D. Leach, Natascia Tiso, Francesco Argenton. Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. Disease Models & Mechanisms 2014; doi: 10.1242/dmm.014969
|
54 |
Mikhail Durymanov, Christian Kroll, Anastasia Permyakova, Elizabeth O'Neill, Raed Sulaiman, Michael Person, Joshua Reineke. Subcutaneous Inoculation of 3D Pancreatic Cancer Spheroids Results in Development of Reproducible Stroma-Rich Tumors. Translational Oncology 2019; 12(1): 180 doi: 10.1016/j.tranon.2018.10.003
|
55 |
Patrick L. Garcia, Aubrey L. Miller, Karina J. Yoon. Patient-Derived Xenograft Models of Pancreatic Cancer: Overview and Comparison with Other Types of Models. Cancers 2020; 12(5): 1327 doi: 10.3390/cancers12051327
|
56 |
Matthias Bozza, Edward W. Green, Elisa Espinet, Alice De Roia, Corinna Klein, Vanessa Vogel, Rienk Offringa, James A. Williams, Martin Sprick, Richard P. Harbottle. Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models. Molecular Therapy - Methods & Clinical Development 2020; 17: 957 doi: 10.1016/j.omtm.2020.04.017
|
57 |
Richard L. Sleightholm, Beth K. Neilsen, Jing Li, Maria M. Steele, Rakesh K. Singh, Michael A. Hollingsworth, David Oupicky. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. Pharmacology & Therapeutics 2017; 179: 158 doi: 10.1016/j.pharmthera.2017.05.012
|
58 |
Guillermo Urrutia, Thiago Milech de Assuncao, Angela J. Mathison, Ann Salmonson, Romica Kerketta, Atefeh Zeighami, Timothy J. Stodola, Volkan Adsay, Burcin Pehlivanoglu, Michael B. Dwinell, Michael T. Zimmermann, Juan L. Iovanna, Raul Urrutia, Gwen Lomberk. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.681153
|
59 |
Gwen A. Lomberk, Raul Urrutia. The Triple-Code Model for Pancreatic Cancer. Surgical Clinics of North America 2015; 95(5): 935 doi: 10.1016/j.suc.2015.05.011
|
60 |
Dustin M. Walters, Jayme B. Stokes, Sara J. Adair, Edward B. Stelow, Cheryl A. Borgman, Bryce T. Lowrey, Wenjun Xin, Edik M. Blais, Jae K. Lee, Jason A. Papin, J. Thomas Parsons, Todd W. Bauer, Michel M. Ouellette. Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human Specimens. PLoS ONE 2013; 8(10): e77065 doi: 10.1371/journal.pone.0077065
|
61 |
Nicholas F. Brown, Elizabeth R. Murray, Lauren C. Cutmore, Philip Howard, Luke Masterson, Francesca Zammarchi, John A. Hartley, Patrick H. van Berkel, John F. Marshall. Integrin-αvβ6 targeted peptide-toxin therapy in a novel αvβ6-expressing immunocompetent model of pancreatic cancer. Pancreatology 2024; 24(3): 445 doi: 10.1016/j.pan.2024.02.013
|
62 |
Nicole M. Sodir, Roderik M. Kortlever, Valentin J.A. Barthet, Tania Campos, Luca Pellegrinet, Steven Kupczak, Panayiotis Anastasiou, Lamorna Brown Swigart, Laura Soucek, Mark J. Arends, Trevor D. Littlewood, Gerard I. Evan. MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype. Cancer Discovery 2020; 10(4): 588 doi: 10.1158/2159-8290.CD-19-0435
|
63 |
Kavita Mallya, Shailendra K. Gautam, Abhijit Aithal, Surinder K. Batra, Maneesh Jain. Modeling pancreatic cancer in mice for experimental therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188554 doi: 10.1016/j.bbcan.2021.188554
|
64 |
Davit Hakobyan, Chantal Médina, Nathalie Dusserre, Marie-Laure Stachowicz, Charles Handschin, Jean-Christophe Fricain, Julie Guillermet-Guibert, Hugo Oliveira. Laser-assisted 3D bioprinting of exocrine pancreas spheroid models for cancer initiation study. Biofabrication 2020; 12(3): 035001 doi: 10.1088/1758-5090/ab7cb8
|
65 |
Chen Liang, Zhen Wang, Li Wu, Chen Wang, Bao-Hua Yu, Xiu-Zhong Yao, Xiao-Lin Wang, Ying-Yi Li. Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene. Tumor Biology 2015; 36(10): 7557 doi: 10.1007/s13277-015-3471-6
|
66 |
Yalda Zolghadri, Shreoshi Pal Choudhuri, Ozhan Ocal, Somayeh Layeghi-Ghalehsoukhteh, Feaven Berhe, Michael A. Hale, Thomas M. Wilkie. Malnutrition in Pancreatic Ductal Adenocarcinoma (PDA). The American Journal of Pathology 2018; 188(3): 616 doi: 10.1016/j.ajpath.2017.11.014
|
67 |
Mami Takahashi, Mika Hori, Rikako Ishigamori, Michihiro Mutoh, Toshio Imai, Hitoshi Nakagama. Fatty pancreas: A possible risk factor for pancreatic cancer in animals and humans. Cancer Science 2018; 109(10): 3013 doi: 10.1111/cas.13766
|
68 |
Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, James Russell, Josef Leibold, Paul B. Romesser, Janelle Simon, Amanda Kulick, Yu-jui Ho, Myles Fennell, Jinyang Li, Robert J. Norgard, John E. Wilkinson, Direna Alonso-Curbelo, Ramya Sridharan, Daniel A. Heller, Elisa de Stanchina, Ben Z. Stanger, Charles J. Sherr, Scott W. Lowe. Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer. Cell 2020; 181(2): 424 doi: 10.1016/j.cell.2020.03.008
|
69 |
Toshihiro Morita, Yuzo Kodama, Masahiro Shiokawa, Katsutoshi Kuriyama, Saiko Marui, Takeshi Kuwada, Yuko Sogabe, Tomoaki Matsumori, Nobuyuki Kakiuchi, Teruko Tomono, Atsushi Mima, Tatsuki Ueda, Motoyuki Tsuda, Yuki Yamauchi, Yoshihiro Nishikawa, Yojiro Sakuma, Yuji Ota, Takahisa Maruno, Norimitsu Uza, Takashi Nagasawa, Tsutomu Chiba, Hiroshi Seno. CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma. Cancer Research 2020; 80(19): 4058 doi: 10.1158/0008-5472.CAN-19-2745
|
70 |
Melika Rezaee, Jing Wang, Mehdi Razavi, Gang Ren, Fengyan Zheng, Ahmed Hussein, Mujib Ullah, Avnesh S. Thakor. A Study Comparing the Effects of Targeted Intra-Arterial and Systemic Chemotherapy in an Orthotopic Mouse Model of Pancreatic Cancer. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52490-1
|
71 |
Elizabeth A. Germino, Joseph P. Miller, Lauri Diehl, Carter J. Swanson, Steffen Durinck, Zora Modrusan, Jeffrey H. Miner, Andrey S. Shaw, Murray Korc. Homozygous KSR1 deletion attenuates morbidity but does not prevent tumor development in a mouse model of RAS-driven pancreatic cancer. PLOS ONE 2018; 13(3): e0194998 doi: 10.1371/journal.pone.0194998
|
72 |
María P. Torres, Satyanarayana Rachagani, Joshua J. Souchek, Kavita Mallya, Sonny L. Johansson, Surinder K. Batra, Fazlul H. Sarkar. Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy. PLoS ONE 2013; 8(11): e80580 doi: 10.1371/journal.pone.0080580
|
73 |
Justin A. Kenkel, William W. Tseng, Matthew G. Davidson, Lorna L. Tolentino, Okmi Choi, Nupur Bhattacharya, E. Scott Seeley, Daniel A. Winer, Nathan E. Reticker-Flynn, Edgar G. Engleman. An Immunosuppressive Dendritic Cell Subset Accumulates at Secondary Sites and Promotes Metastasis in Pancreatic Cancer. Cancer Research 2017; 77(15): 4158 doi: 10.1158/0008-5472.CAN-16-2212
|
74 |
Bayan Al-Share, Nour Hammad, Maria Diab. Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy. Cancer and Metastasis Reviews 2021; 40(1): 355 doi: 10.1007/s10555-020-09948-w
|
75 |
Bohan Zhan, Shi Wen, Jie Lu, Guiping Shen, Xianchao Lin, Jianghua Feng, Heguang Huang. Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer. Oncotarget 2017; 8(37): 61264 doi: 10.18632/oncotarget.18057
|
76 |
A K Thakur, J Nigri, S Lac, J Leca, C Bressy, P Berthezene, L Bartholin, P Chan, E Calvo, J L Iovanna, S Vasseur, F Guillaumond, R Tomasini. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death & Differentiation 2016; 23(8): 1358 doi: 10.1038/cdd.2016.18
|
77 |
Chia-Chi Chen, Li-Li Chen, Chung-Pin Li, Yu-Ting Hsu, Shih-Sheng Jiang, Chi-Shuan Fan, Kee Voon Chua, Sheng-Xiang Huang, Yi-Ming Shyr, Li-Tzong Chen, Tze-Sing Huang. Myeloid-derived macrophages and secreted HSP90α induce pancreatic ductal adenocarcinoma development. OncoImmunology 2018; 7(5): e1424612 doi: 10.1080/2162402X.2018.1424612
|
78 |
Zeynep Nur Senturk, Isilay Akdag, Bahar Deniz, Ayca Sayi-Yazgan. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1152551
|
79 |
Michael W. Pickup, Philip Owens, Agnieszka E. Gorska, Anna Chytil, Fei Ye, Chanjuan Shi, Valerie M. Weaver, Raghu Kalluri, Harold L. Moses, Sergey V. Novitskiy. Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells. Cancer Immunology Research 2017; 5(9): 718 doi: 10.1158/2326-6066.CIR-16-0311
|
80 |
Peter W. Nagle, John Th. M. Plukker, Christina T. Muijs, Peter van Luijk, Robert P. Coppes. Patient-derived tumor organoids for prediction of cancer treatment response. Seminars in Cancer Biology 2018; 53: 258 doi: 10.1016/j.semcancer.2018.06.005
|
81 |
Begum Dariya, Afroz Alam, Ganji Purnachandra Nagaraju. Theranostic Approach for Pancreatic Cancer. 2019; : 1 doi: 10.1016/B978-0-12-819457-7.00001-3
|
82 |
Maya Saison-Ridinger, Kathleen E. DelGiorno, Tejia Zhang, Annabelle Kraus, Randall French, Dawn Jaquish, Crystal Tsui, Galina Erikson, Benjamin T. Spike, Maxim N. Shokhirev, Christopher Liddle, Ruth T. Yu, Michael Downes, Ronald M. Evans, Alan Saghatelian, Andrew M. Lowy, Geoffrey M. Wahl, Martin Fernandez-Zapico. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy. PLOS ONE 2017; 12(12): e0189051 doi: 10.1371/journal.pone.0189051
|
83 |
Marcel A. Heinrich, Ahmed M.R.H. Mostafa, Jennifer P. Morton, Lukas J.A.C. Hawinkels, Jai Prakash. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Advanced Drug Delivery Reviews 2021; 174: 265 doi: 10.1016/j.addr.2021.04.018
|
84 |
John Silke, Lorraine Ann O’Reilly. NF-κB and Pancreatic Cancer; Chapter and Verse. Cancers 2021; 13(18): 4510 doi: 10.3390/cancers13184510
|
85 |
Simone Polvani, Mirko Tarocchi, Sara Tempesti, Lapo Bencini, Andrea Galli. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer. World Journal of Gastroenterology 2016; 22(8): 2441-2459 doi: 10.3748/wjg.v22.i8.2441
|
86 |
Chia-Ning Shen, King-Siang Goh, Chi-Ruei Huang, Tsai-Chen Chiang, Chih-Yuan Lee, Yung-Ming Jeng, Shih-Jung Peng, Hung-Jen Chien, Mei-Hsin Chung, Ya-Hsien Chou, Chi-Che Hsieh, Subhash Kulkarni, Pankaj J. Pasricha, Yu-Wen Tien, Shiue-Cheng Tang. Lymphatic vessel remodeling and invasion in pancreatic cancer progression. EBioMedicine 2019; 47: 98 doi: 10.1016/j.ebiom.2019.08.044
|
87 |
Pia Gamradt, Kevin Thierry, Melissa Masmoudi, Zhichong Wu, Hector Hernandez-Vargas, Sophie Bachy, Tiffanie Antonio, Berkan Savas, Zainab Hussain, Richard Tomasini, Pascale Milani, Philippe Bertolino, Ana Hennino, David Brenner. Stiffness-induced cancer-associated fibroblasts are responsible for immunosuppression in a platelet-derived growth factor ligand-dependent manner. PNAS Nexus 2023; 2(12) doi: 10.1093/pnasnexus/pgad405
|
88 |
Jieli Shen, Dat P. Ha, Genyuan Zhu, Daisy F. Rangel, Agnieszka Kobielak, Parkash S. Gill, Susan Groshen, Louis Dubeau, Amy S. Lee.
GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant
Kras
-driven pancreatic tumorigenesis in mice
. Proceedings of the National Academy of Sciences 2017; 114(20) doi: 10.1073/pnas.1616060114
|
89 |
Corina Kim-Fuchs, Caroline P. Le, Matthew A. Pimentel, David Shackleford, Davide Ferrari, Eliane Angst, Frédéric Hollande, Erica K. Sloan. Chronic stress accelerates pancreatic cancer growth and invasion: A critical role for beta-adrenergic signaling in the pancreatic microenvironment. Brain, Behavior, and Immunity 2014; 40: 40 doi: 10.1016/j.bbi.2014.02.019
|
90 |
Umashankar K. Ballehaninna, Ronald S. Chamberlain. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. Tumor Biology 2013; 34(6): 3279 doi: 10.1007/s13277-013-1033-3
|
91 |
Jorge Franco, Agnieszka K. Witkiewicz, Erik S. Knudsen. CDK4/6 inhibitors have potent activity in combination with pathway selective therapeutic agents in models of pancreatic cancer. Oncotarget 2014; 5(15): 6512 doi: 10.18632/oncotarget.2270
|
92 |
Giulia Gasparini, Marta Pellegatta, Stefano Crippa, Marco Schiavo Lena, Giulio Belfiori, Claudio Doglioni, Carla Taveggia, Massimo Falconi. Nerves and Pancreatic Cancer: New Insights into A Dangerous Relationship. Cancers 2019; 11(7): 893 doi: 10.3390/cancers11070893
|
93 |
Milena Muzzolini, Ismahane Belhabib, Victoire Cardot, Annemilaï Tijeras-Raballand, Cindy Neuzillet, Corinne Bousquet, Renato Micelli Lupinacci, Christine Jean. Pancreatic cancer orthotopic graft in a murine model. Acta Cirúrgica Brasileira 2023; 38 doi: 10.1590/acb382823
|
94 |
Anne Steins, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven. Conn's Handbook of Models for Human Aging. 2018; : 735 doi: 10.1016/B978-0-12-811353-0.00054-3
|
95 |
Molly C. Holbrook, Dakota W. Goad, Valery Z. Grdzelishvili. Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions. Cancers 2021; 13(5): 1171 doi: 10.3390/cancers13051171
|
96 |
Min Ju Kim, Hyeyoun Chang, Gihoon Nam, Youngji Ko, Sun Hwa Kim, Thomas M. Roberts, Ju Hee Ryu. RNAi-Based Approaches for Pancreatic Cancer Therapy. Pharmaceutics 2021; 13(10): 1638 doi: 10.3390/pharmaceutics13101638
|
97 |
Hiroyoshi Y. Tanaka, Takuya Nakazawa, Takuya Miyazaki, Horacio Cabral, Atsushi Masamune, Mitsunobu R. Kano. Targeting ROCK2 improves macromolecular permeability in a 3D fibrotic pancreatic cancer microenvironment model. Journal of Controlled Release 2024; 369: 283 doi: 10.1016/j.jconrel.2024.03.041
|
98 |
Rossana Ritelli, Raphael Ngalani Ngaleu, Pietro Bontempi, Mario Dandrea, Elena Nicolato, Federico Boschi, Silvia Fiorini, Laura Calderan, Aldo Scarpa, Pasquina Marzola. Pancreatic cancer growth using magnetic resonance and bioluminescence imaging. Magnetic Resonance Imaging 2015; 33(5): 592 doi: 10.1016/j.mri.2015.02.017
|
99 |
Jun Zhao, Huamin Wang, Cheng-Hui Hsiao, Diana S.-L. Chow, Eugene J. Koay, Yaan Kang, Xiaoxia Wen, Qian Huang, Ying Ma, James A. Bankson, Stephen E. Ullrich, Willem Overwijk, Anirban Maitra, David Piwnica-Worms, Jason B. Fleming, Chun Li. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Biomaterials 2018; 159: 215 doi: 10.1016/j.biomaterials.2018.01.014
|
100 |
Victor M. Blanco, Tahir Latif, Zhengtao Chu, Xiaoyang Qi. Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Nanovesicles. Translational Oncology 2015; 8(3): 196 doi: 10.1016/j.tranon.2015.03.011
|
101 |
Meike Beer, Nirmala Kuppalu, Matteo Stefanini, Holger Becker, Ingo Schulz, Sagar Manoli, Julia Schuette, Christian Schmees, Armando Casazza, Martin Stelzle, Annarosa Arcangeli. A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01256-8
|
102 |
Deepitha Selvaraj, Michael Hirth, Jagadeesh Gandla, Rohini Kuner. A mouse model for pain and neuroplastic changes associated with pancreatic ductal adenocarcinoma. Pain 2017; 158(8): 1609 doi: 10.1097/j.pain.0000000000000956
|
103 |
N V Rajeshkumar, Shinichi Yabuuchi, Shweta G Pai, Zeen Tong, Shihe Hou, Scott Bateman, Daniel W Pierce, Carla Heise, Daniel D Von Hoff, Anirban Maitra, Manuel Hidalgo. Superior therapeutic efficacy of nab-paclitaxel over cremophor-based paclitaxel in locally advanced and metastatic models of human pancreatic cancer. British Journal of Cancer 2016; 115(4): 442 doi: 10.1038/bjc.2016.215
|
104 |
Ofejiro Blessing Pereye, Yuko Nakagawa, Takashi Sato, Ayako Fukunaka, Shuhei Aoyama, Yuya Nishida, Wakana Mizutani, Nanami Kobayashi, Yohei Morishita, Tetsunari Oyama, Reika Kawabata‐Iwakawa, Hirotaka Watada, Hiroki Mizukami, Akihisa Fukuda, Yoshio Fujitani. Identification of Ppy‐lineage cells as a novel origin of pancreatic ductal adenocarcinoma. The Journal of Pathology 2024; 263(4-5): 429 doi: 10.1002/path.6295
|
105 |
Audrey M. Hendley, Jennifer M. Bailey. Principles of Stem Cell Biology and Cancer. 2015; : 213 doi: 10.1002/9781118670613.ch11
|
106 |
Agnieszka Smolinska, Kerstin Singer, Janine Golchert, Urszula Smyczynska, Wojciech Fendler, Matthias Sendler, Jens van den Brandt, Stephan Singer, Georg Homuth, Markus M. Lerch, Patryk Moskwa. DNA Polymerase Theta Plays a Critical Role in Pancreatic Cancer Development and Metastasis. Cancers 2022; 14(17): 4077 doi: 10.3390/cancers14174077
|
107 |
Inwon Park, Sujung Hong, Yoonha Hwang, Pilhan Kim. A Novel Pancreatic Imaging Window for Stabilized Longitudinal In Vivo Observation of Pancreatic Islets in Murine Model. Diabetes & Metabolism Journal 2020; 44(1): 193 doi: 10.4093/dmj.2018.0268
|
108 |
Daniele Pereira Ferrari, Fernanda Ramos-Gomes, Frauke Alves, M. Andrea Markus. KPC-luciferase-expressing cells elicit an anti-tumor immune response in a mouse model of pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64053-0
|
109 |
Bincy Philip, Christina L. Roland, Jaroslaw Daniluk, Yan Liu, Deyali Chatterjee, Sobeyda B. Gomez, Baoan Ji, Haojie Huang, Huamin Wang, Jason B. Fleming, Craig D. Logsdon, Zobeida Cruz–Monserrate. A High-Fat Diet Activates Oncogenic Kras and COX2 to Induce Development of Pancreatic Ductal Adenocarcinoma in Mice. Gastroenterology 2013; 145(6): 1449 doi: 10.1053/j.gastro.2013.08.018
|